Member Info for demolition123

We all are hoping for that but if it's not what we are hoping for worst case scenario it will drop to 20p -25p we know it will pick up within a couple of weeks as this has legs so dont why anyone would panic sell.Only be the ones hoping for a quick profit,I am staying for the takeover and I think it will be quick in coming,so much going for genedrive now national and global roll out plus the stroke thing to come

AZ must have something now,we are waiting

I can see loads getting locked out here leaving to the last minute,at the end of the day this has legs in the long term so like a lot of us we will not sell,so the normal aim tactics wont make any difference in trying to get us to sell our golden tickets

Holding this back now me thinks

Wouldn't worry about it its normal for aim lead everyone into a false sence of security,then people panic price falls and then all pile back in manulipation at it's best,Robin hood comes to mind dont let them have your golden tickets,we all no were this is heading problem today and in this current climate everyone wants to make a fast buck as quick as possible

Peakhope,Savvy,hughes87 loved the possitivity you have shown towards Syme I share your confidence we our all adults and no what the risks our hope one day in the near future meet up and celebrate symes success,you never know king AZ might invite us round for tea Syme Global ££££

OUR WE THERE YET ?

On a more serious note this has to be one of the best long term aim shares with legs and wouldn't surprise me on a takeover approach at anytime even in the next few weeks,this is obviously going global will go many multiples of todays price one for the pension pot

It will only be the ones who want to make a quick profit who our wetting there pants,anyone bourght in for the long term investment,safe as houses this has legs and will multiply several times before now and then 3-5 years or longer but I am expecting a takeover well before then,Its not out of the question it may happen within the next 3 years,imagine any speculation of it this will go nuts,Mr budd name your price ?

Yep you dont want to be out now,this is going to get really exciting

Dont know what's going on Up Down Up Down,holding strong we invested here in the first place and still believe in the concept,with everything heading to digitization it will take of in my opion

I am greedy I say £4 plus on a buy out looking at the other take overs in the last 6 months and I am going to say that is vary plausible in the next few weeks let's see what happens between now and then good luck all LTH

Wouldnt surprise me now at this point in the game

Locked and loaded just a waiting game now,come on Genedrive spill the beans

This will go nuts hopefully this week at some point so not taking any chances being out now,I can live with oh well it was a gamble,but cant live with what ifs bring on the RNS

I would be vary surprised if they dont get funding,but I am going to wait for the take over,like to be a fly on the wall when the bigger pharmaceutical companies try and muscle in,mr budd I have a blank cheque here name your price,money talks then watch loads get locked out feeling sick as parrots

So glad I bailed out here the so called device that the professor was praising about what happened to that ?

Mad selling out now in my opinion,if the RNS drops out now your be crying in your tea and its very possible it could come before the 31st load up this has real legs

Professor Bill Newman, PALOH study lead and Consultant in Genomic Medicine at MFT highlights the benefits of the Genedrive® MT-RNR1 ID Kit, one of the 1st products to be assessed by #NICE in their new EVA programme.
??Full report next week
#GDR #NHS #POCT #pharmacogenetics

Might be way of here I wonder if the money from the TF boys will go to Dominic White to fund the digital bank he is setting up and its linked into symes digitization IMs,I believe he was trying to arrange 50 million,just my thourghts as there a lot cleverer than most of us,not saying anyones thick

Professor Bill Newman, PALOH study lead and Consultant in Genomic Medicine at MFT highlights the benefits of the Genedrive® MT-RNR1 ID Kit, one of the 1st products to be assessed by #NICE in their new EVA programme.
??Full report next week
#GDR #NHS #POCT #pharmacogenetic